Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SC-004 |
Trade Name | |
Synonyms | SC004|SC 004 |
Drug Descriptions |
SC-004 is a CLDN6/9-targeted antibody-drug conjugate (ADC) linked to a DNA cross-linking agent, with potential antitumor activity (Cancer Res (2020) 80 (16_Supplement): CT124). |
DrugClasses | CLDN6 Antibody 8 |
CAS Registry Number | NA |
NCIT ID | C136807 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Budigalimab + SC-004 | Budigalimab SC-004 | 0 | 1 |
SC-004 | SC-004 | 0 | 1 |